Brief: Cipher Pharmaceuticals Reports Q4 Results
16/03/2023 21:34
March 16 (Reuters) - Cipher Pharmaceuticals Inc
CPH.TO :
* CIPHER PHARMACEUTICALS INC Q4 REVENUE $4.9 MILLION VERSUS
$5.9
MILLION
* CIPHER PHARMACEUTICALS INC - QTRLY EARNINGS PER COMMON
SHARE
WERE $0.78 COMPARED TO $0.11 IN Q4 2021
Source text for Eikon: ID:nCNW1L5VNa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million